Animal Dermatology Group

Animal Dermatology Group

Animal Dermatology Group (ADG) was built by aggregating independent specialty practices into a single brand focused exclusively on veterinary dermatology. The company's physicians are diplomates of the American College of Veterinary Dermatology, a credential held by fewer than 400 veterinarians nationwide. By concentrating these scarce specialists, ADG captures referral cases from general-practice vets who lack the expertise to manage complex atopy, food allergy, and autoimmune skin diseases. The group maintains clinical sites across multiple states including California, Texas, Georgia, and Washington, with a central laboratory in Irvine that processes allergy serology for both ADG clinics and external referring veterinarians. ADG's strategy pairs a clinical service network with a proprietary allergy-testing and immunotherapy manufacturing operation. The central lab produces allergen-specific immunotherapy formulations — custom treatment serums that represent a recurring pharmaceutical revenue line alongside in-clinic visits. The company deploys capital into acquiring new specialty practices, upgrading diagnostic equipment, and expanding the lab's testing capacity. Unlike general veterinary consolidators that buy large animal hospitals, ADG targets a narrow sub-specialty where patient caseloads are referral-driven and competitors are sparse. Referral relationships with general practitioners create a durable sourcing moat, as dermatology cases are chronic and require ongoing management. The group maintains what it describes as the largest veterinary dermatology database in the world, aggregated from decades of clinical cases across its network — a data asset that informs treatment protocols and allergy-immunotherapy formulations. ADG's organizational structure places a board-certified dermatologist at the helm of clinical governance, ensuring that practice standards are set by specialists rather than lay managers. While the group has not disclosed its private equity backing or ownership structure publicly, its multi-site partnership model suggests institutional capital of the type common in specialty physician practice management platforms. ADG's architectural difference is its grip on a scarce professional credential. With only a few hundred board-certified veterinary dermatologists practicing in the U.S., the company's aggregation of these specialists creates a barrier that general-practice chains cannot easily replicate by simply hiring more vets. The central allergy lab adds a manufacturing component absent from most veterinary service platforms, giving the group an additional revenue stream that scales independently of clinic appointment volume.